These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial. Takeuchi H; Lee J; Fervaha G; Foussias G; Agid O; Remington G J Clin Psychiatry; 2017 Feb; 78(2):223-228. PubMed ID: 28234436 [TBL] [Abstract][Full Text] [Related]
44. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases. Friedman JH Mov Disord; 1994 May; 9(3):321-4. PubMed ID: 7913739 [TBL] [Abstract][Full Text] [Related]
45. Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivation. Kreinin A; Miodownik C; Sokolik S; Shestakova D; Libov I; Bergman J; Lerner V World J Biol Psychiatry; 2011 Dec; 12(8):620-6. PubMed ID: 20964499 [TBL] [Abstract][Full Text] [Related]
46. Aripiprazole in treatment-refractory schizophrenia. Hsu WY; Lee CI; Chiu NY; Kahn DA J Psychiatr Pract; 2009 May; 15(3):221-6. PubMed ID: 19461396 [TBL] [Abstract][Full Text] [Related]
47. Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever. Kluge M; Schuld A; Schacht A; Himmerich H; Dalal MA; Wehmeier PM; Hinze-Selch D; Kraus T; Dittmann RW; Pollmächer T Psychoneuroendocrinology; 2009 Jan; 34(1):118-28. PubMed ID: 18835660 [TBL] [Abstract][Full Text] [Related]
49. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle. Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885 [TBL] [Abstract][Full Text] [Related]
50. Combined use of clozapine and ECT: a review. Grover S; Hazari N; Kate N Acta Neuropsychiatr; 2015 Jun; 27(3):131-42. PubMed ID: 25697225 [TBL] [Abstract][Full Text] [Related]
51. Risperidone augmentation of clozapine: a critical review. Kontaxakis VP; Ferentinos PP; Havaki-Kontaxaki BJ; Paplos KG; Pappa DA; Christodoulou GN Eur Arch Psychiatry Clin Neurosci; 2006 Sep; 256(6):350-5. PubMed ID: 16900439 [TBL] [Abstract][Full Text] [Related]
52. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand. Wheeler AJ Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732 [TBL] [Abstract][Full Text] [Related]
53. The augmentation of clozapine treatment with electroconvulsive therapy. Gazdag G; Kocsis-Ficzere N; Tolna J Ideggyogy Sz; 2006 Jul; 59(7-8):261-7. PubMed ID: 17076304 [TBL] [Abstract][Full Text] [Related]
54. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder. Lerner V; Libov I; Kotler M; Strous RD Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):89-98. PubMed ID: 14687862 [TBL] [Abstract][Full Text] [Related]
55. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review]. Simon L; Cazard F Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327 [TBL] [Abstract][Full Text] [Related]
57. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing]. Mercier C; Bret P; Bret MC; Queuille E Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368 [TBL] [Abstract][Full Text] [Related]
58. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702 [TBL] [Abstract][Full Text] [Related]
59. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis. Hägg S; Rosenius S; Spigset O Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898 [TBL] [Abstract][Full Text] [Related]